REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Shanghai Bio-heart Biological Technology Company Limited (China)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: Shanghai Bio-heart Biological Technology Company Limited Profile Updated: October 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shanghai Bio-heart Biological Technology Company Limited focuses on the R&D and production of interventional cardiovascular devices. The company's main products include fully degradable stents and renal nerve blocking. The company was founded in 2014 and headquartered in Shanghai City, China.

Headquarters
Room 302, 3/F, Building 4, No.590 Ruiqing Road, East Zhangjiang Hi-Tech Park, Pudong New Area
Shanghai; Shanghai;

Contact Details: Purchase the Shanghai Bio-heart Biological Technology Company Limited report to view the information.

Website: http://www.bio-heart.com

Basic Information
Total Employees:
Purchase the Shanghai Bio-heart Biological Technology Company Limited report to view the information.
Outstanding Shares:
Purchase the Shanghai Bio-heart Biological Technology Company Limited report to view the information.
Registered Capital:
Purchase the Shanghai Bio-heart Biological Technology Company Limited report to view the information.
Financial Auditors:
Purchase the Shanghai Bio-heart Biological Technology Company Limited report to view the information.
Incorporation Date:
July 01, 2014
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
19.32%
Purchase this report to view the information.
11.84%
Purchase this report to view the information.
10.75%
Purchase this report to view the information.
8.79%
Purchase this report to view the information.
7.08%
Subsidiaries
Hong Kong Bio-Heart Biological Technology Co., Limited (Hong Kong SAR, China)
100%
Shanghai Angiocare Medical Technology Co., Ltd.
65.69%
Company Performance
Financial values in the chart are available after Shanghai Bio-heart Biological Technology Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Total operating revenue
-1.63%▼
Operating profit (EBIT)
70.37%▲
EBITDA
70.74%▲
Net Profit (Loss) for the Period
70.22%▲
Total assets
-13.98%▼
Total equity
-12.59%▼
Return on Equity (ROE)
7.35%▲
Debt to Equity Ratio
-1.67%▼
Quick Ratio
6.61%▲
Cash Ratio
3.82%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo